| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |